Abstract
Antibiotic activity can differ depending on whether the bacterial target is extracellular or intracellular. To determine extracellular and intracellular activities of sitafloxacin (STX) against Staphylococcus aureus in comparison with levofloxacin (LVX) and moxifloxacin (MXF) in vivo and in vitro, three S. aureus strains (ATCC25923, 29213, 43300) were evaluated. MIC, MBC and mutant prevention concentration (MPC) of the test quinolone for S. aureus were determined by microdilution in broth, and intracellular activity was determined in RAW264.7 cells after phagocytosis of bacteria. Cellular quinolone accumulation was determined by HPLC. The time- and concentration-kill relationships were examined in vitro (in broth and in RAW264.7 cells, respectively) and in vivo by use of a mouse peritonitis model. The results showed that the activity of STX in broth cultures, including the MIC, MBC, MPC and the time- and concentration-kill relationships, were greater for STX than those for LVX and MXF. In particular, STX exhibited the strongest activity against intramacrophage S. aureus. The intracellular effects could be ranked in the following order as the mean change in the log10 number of cfu ml(-1) (log10 cfu ml(-1)) between treated and un...Continue Reading
References
Sep 1, 1978·Cell·W C RaschkeI Nakoinz
Sep 1, 1991·The American Review of Respiratory Disease·H TomiokaT Yoneyama
Dec 16, 1983·Journal of Immunological Methods·T Mosmann
Mar 21, 1998·Archives of Internal Medicine·A G JensenN Frimodt-Møller
Jul 25, 2000·Postgraduate Medical Journal·J Ciampolini, K G Harding
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·X Zhao, K Drlica
Oct 12, 2001·Apoptosis : an International Journal on Programmed Cell Death·M EsenE Gulbins
Feb 28, 2002·The Journal of Infectious Diseases·Xilin Zhao, Karl Drlica
Oct 8, 2003·Medicine·Feng-Yee ChangVictor L Yu
May 22, 2004·Journal of the American Academy of Dermatology·Shilesh Iyer, Derek H Jones
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Françoise Van BambekePaul M Tulkens
Jun 21, 2005·Emerging Infectious Diseases·Matthew J KuehnertDaniel B Jernigan
Jun 24, 2005·JAMA : the Journal of the American Medical Association·Vance G FowlerUNKNOWN ICE Investigators
Feb 24, 2006·Antimicrobial Agents and Chemotherapy·Maritza Barcia-MacayFrançoise Van Bambeke
Mar 18, 2006·BMC Infectious Diseases·Michael PedersenAllan G Jensen
Oct 26, 2006·The Journal of Antimicrobial Chemotherapy·Maritza Barcia-MacayFrançoise Van Bambeke
May 4, 2007·International Journal of Antimicrobial Agents·Anna M Ferrara
Jun 12, 2008·The Journal of Antimicrobial Chemotherapy·Sébastien Van de VeldeMarie-Claude Saux
Jun 25, 2008·Antimicrobial Agents and Chemotherapy·Ann LismondFrançoise Van Bambeke
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Anne SandbergNiels Frimodt-Møller
Mar 18, 2009·Antimicrobial Agents and Chemotherapy·Sandrine LemaireFrançoise Van Bambeke
Apr 10, 2010·The Journal of Antimicrobial Chemotherapy·Pierre BaudouxYouri Glupczynski
Apr 21, 2011·Drugs·Gillian M Keating
Citations
Jun 6, 2015·Scientific Reports·Huanhuan LiKhulal Urmila
Mar 8, 2014·Acta Cirúrgica Brasileira·Maria Cecília Santos Cavalcanti MeloCarlos Teixeira Brandt
Nov 7, 2019·Journal of Medical Microbiology·Jacques Dubois, Maïtée Dubois
Feb 15, 2018·ACS Applied Materials & Interfaces·Qian CaiHao Wang
Sep 1, 2021·Acta Pharmacologica Sinica·Xiao-Yang ChenJing-Wei Zhang